SCLC Consortium Meeting (Abstract Submission)

Submitted by nusratyj on

Abstract Submission

Use the form below to submit a single abstract.  Abstracts are used to inform the agenda based the session topics.  Although abstract submission is not required to attend the meeting, in-person meeting attendance is required if the abstract is selected by the scientific committee for either oral or poster presentation.  Abstract submitters will choose a session topic, however, there is a possibility that the topic selected will be changed by the scientific committee for agenda balance. 

The session topics are:    

Session 1: Biology
Session 2: Models
Session 3: Tumor Heterogeneity & Plasticity
Session 4: New Therapy Targets
Session 5: Treatment Resistance
Session 6: Immunology and Immunotherapy

Abstract Submission Deadline: Friday, March 13, 2026 by 3pm EST.  Confirmation emails will be sent upon submission.

Abstract submission questions can be addressed to Emily Hanlen.

Please register before submitting an abstract.

 

OMB No.: 0925-0740
Expiration Date: 11/30/2028

Public reporting burden for this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.

Abstract Submission
How do you plan to attend?

Abstract Submitter's Name

First Author
Affiliation; abbreviations are welcome
Additional Authors
First Name Last Name Post-nominal letters Affiliation
more items
Topic Classification

Abstract Submission Instructions:

  • Abstract size is limited to 350 word maximum.
  • Bold and italics are not allowed.
  • Special characters are permitted.
  • Images and hyperlinks are not allowed.
  • All abstracts will be collated into a publicly published abstract book that will be distributed via email initially but will eventually be hosted on the TRP website (trp.cancer.gov).
  • Abstract submission questions can be addressed to Emily Hanlen.